Gene · 716
Papers3,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current Treatment Options in Cold Agglutinin Disease: B-Cell Directed or Complement Directed Therapy? | Transfus Med Rev | 2022 | 36127205 | PubTator, text mining | PubMed |
| Hemizygous nonsense variant in the moesin gene (MSN) leads to a new autoimmune phenotype of Immunodeficiency 50. | Front Immunol | 2022 | 36119109 | PubTator, text mining | PubMed |
| Prognostic and immune-related value of complement C1Q (C1QA, C1QB, and C1QC) in skin cutaneous melanoma. | Front Genet | 2022 | 36110204 | PubTator, text mining | PubMed |
| SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 protein. | PLoS Pathog | 2022 | 36095012 | PubTator, text mining | PubMed |
| Deceiving and escaping complement - the evasive journey of the malaria parasite. | Trends Parasitol | 2022 | 36089499 | PubTator, text mining | PubMed |
| A bloody interaction: plasma proteomics reveals gilthead sea bream (Sparus aurata) impairment caused by Sparicotyle chrysophrii. | Parasit Vectors | 2022 | 36088326 | PubTator, text mining | PubMed |
| Exosome Proteomics Reveals the Deregulation of Coagulation, Complement and Lipid Metabolism Proteins in Gestational Diabetes Mellitus. | Molecules | 2022 | 36080270 | PubTator, text mining | PubMed |
| Anticoagulation Strategies during Extracorporeal Membrane Oxygenation: A Narrative Review. | J Clin Med | 2022 | 36079084 | PubTator, text mining | PubMed |
| Placental damage in pregnancies with systemic lupus erythematosus: A narrative review. | Front Immunol | 2022 | 36059466 | PubTator, text mining | PubMed |
| Common and rare variants in patients with early onset drusen maculopathy. | Clin Genet | 2022 | 36053979 | PubTator, text mining | PubMed |
| The complex formation of MASP-3 with pattern recognition molecules of the lectin complement pathway retains MASP-3 in the circulation. | Front Immunol | 2022 | 36052069 | PubTator, text mining | PubMed |
| IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia. | J Clin Invest | 2022 | 36047494 | PubTator, text mining | PubMed |
| Targeting thromboinflammation in COVID-19 - A narrative review of the potential of C1 inhibitor to prevent disease progression. | Mol Immunol | 2022 | 36030710 | PubTator, text mining | PubMed |
| Coagulation and complement: Key innate defense participants in a seamless web. | Front Immunol | 2022 | 36016942 | PubTator, text mining | PubMed |
| Comparative transcriptome analysis of MDBK cells reveals that BoIFN-γ augmented host immune responses to bovine herpesvirus 1 infection. | Front Microbiol | 2022 | 36016774 | PubTator, text mining | PubMed |
| The Chemokines CXC, CC and C in the Pathogenesis of COVID-19 Disease and as Surrogates of Vaccine-Induced Innate and Adaptive Protective Responses. | Vaccines (Basel) | 2022 | 36016187 | PubTator, text mining | PubMed |
| The Exploration of Complement-Resistance Mechanisms of Pathogenic Gram-Negative Bacteria to Support the Development of Novel Therapeutics. | Pathogens | 2022 | 36015050 | PubTator, text mining | PubMed |
| Double Heteroatom Reconfigured Polar Catalytic Surface Powers High-Performance Lithium-Sulfur Batteries. | Materials (Basel) | 2022 | 36013810 | PubTator, text mining | PubMed |
| Autoantibodies against Complement Classical Pathway Components C1q, C1r, C1s and C1-Inh in Patients with Lupus Nephritis. | Int J Mol Sci | 2022 | 36012546 | PubTator, text mining | PubMed |
| The Role of Extracellular Vesicles in COVID-19 Pathology. | Cells | 2022 | 36010572 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/716/papers?page=32